Abin B. You
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
EZH2 inhibitor Tazemetostat synergizes with JQ-1 in esophageal cancer by inhibiting c-Myc signaling pathway.
Journal: Medical oncology (Northwood, London, England)
Published: March 29, 2023
Single Cell RNA Sequencing Identifies a Unique Inflammatory Macrophage Subset as a Druggable Target for Alleviating Acute Kidney Injury.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 23, 2021
Chidamide increases the sensitivity of Non-small Cell Lung Cancer to Crizotinib by decreasing c-MET mRNA methylation.
Journal: International journal of biological sciences
Published: March 27, 2020
Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice.
Journal: Nature communications
Published: May 13, 2019
Correction: Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models.
Journal: PloS one
Published: October 19, 2018
Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and humans in vitro.
Journal: Hepatology (Baltimore, Md.)
Published: October 11, 2017
Effect of HIF-2α on regulating CDCP1 to promote hepatocellular carcinoma metastasis
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: January 21, 2017
Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
Journal: Journal of hematology & oncology
Published: January 01, 2016
Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30.
Journal: Cancer science
Published: October 22, 2015
Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models.
Journal: PloS one
Published: October 08, 2015
Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro.
Journal: Hepatology (Baltimore, Md.)
Published: September 17, 2015
Last Updated: 09/26/2026